To develop a novel modulator targeting proteostasis for the treatment of M. Tuberculosis.
Active Definitive Contract Awarded Last action
- Contract number
- 75N93024C00008
- Awardee
-
The Global Alliance For TB Drug Development Inc. UEI CA1RNRESAZU6
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,475,623
Award facts
- Opportunity
-
- 2023 NIAID Omnibus Broad Agency Announcement Solicitation · HHSNIHNIAIDBAA20231 · Posted Jan 11, 2023
- Contract value 25% obligated
-
- $2,475,623.00 Current, with exercised options
- $9,851,406.00 Potential, with all options
- Completion date 63% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 18 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- New York, NY 10005, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $2,475,623 |
About this award
The National Institute of Allergy and Infectious Diseases awarded a $9.85 million definitive contract to The Global Alliance For TB Drug Development Inc. on May 10, 2024, to develop a novel modulator targeting proteostasis for the treatment of Mycobacterium tuberculosis under Executive Order 14398. The contract carries cost-no-fee pricing and an ultimate completion date of April 30, 2028.
Place of performance is New York, NY. The solicitation was posted January 11, 2023, with a due date of April 11, 2023.
Service Contract Inventory reporting shows the contract's labor footprint evolved significantly. In FY2024, the awardee invoiced $68 thousand across 0.2 FTEs and 441 contractor hours at a derived rate of $154.91 per hour. In FY2025, invoicing increased to $1.3 million across 6.0 FTEs and 12,368 contractor hours at a derived rate of $105.11 per hour. The blended government-paid hourly rate declined year-over-year. In FY2025, four subcontractors performed 86 percent of contractor hours, reflecting a shift from self-performance in the initial year toward a subcontracted delivery model.
Quick answers
Who was awarded contract 75N93024C00008?
75N93024C00008 was awarded to The Global Alliance For TB Drug Development Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on May 10, 2024.
How much is contract 75N93024C00008 worth?
The government has obligated $2,475,623 on 75N93024C00008. Its potential value, with all options, is $9,851,406.
Was contract 75N93024C00008 competed?
The extent of competition for 75N93024C00008 was full and open competition. The government received 18 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award